XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating expenses:    
Research and development $ 71,255 $ 61,115
General and administrative 15,263 13,300
Goodwill impairment (see Note 2) 32,970 0
4SC Royalty Settlement (See Note 4) 0 17,250
Total operating expenses 119,488 91,665
Loss from operations (119,488) (91,665)
Other income (expense):    
Interest income 1,041 66
Other expense, net (1,960) (1,346)
Total other expense, net (919) (1,280)
Net loss $ (120,407) $ (92,945)
Net loss per share, basic (in USD per share) $ (3.78) $ (3.93)
Net loss per share, diluted (in USD per share) $ (3.78) $ (3.93)
Weighted-average common shares outstanding, basic (in shares) 31,819,006 23,652,779
Weighted-average common shares outstanding, diluted (in shares) 31,819,006 23,652,779